Never miss a story

Get subscribed to our newsletter


×
This illustration provided by the Centers for Disease Control and Prevention in January 2020 shows the 2019 Novel Coronavirus (2019-nCoV). VOA

By Steve Baragona

A vaccine against the new Wuhan coronavirus may start testing in as little as three months, according to National Institute of Allergy and Infectious Diseases Director Anthony Fauci.


That’s fast.

It took 20 months before a vaccine against severe acute respiratory syndrome, SARS, was ready for clinical trials.

That doesn’t mean you can line up for a shot in three months. The vaccine will need to be tested for safety and efficacy. That will take months more.


A staff works at an egg testing workshop of Sinovac Biotech Ltd., a Chinese vaccine-making company, during the production of a vaccine for the H1N1 coronavirus in Beijing. VOA

But the time it takes to go from outbreak to vaccine candidate is shorter than ever, thanks in part to a new kind of vaccine.

Eighteenth century tech

Ever since Edward Jenner developed the first vaccine in the 18th century, against smallpox, vaccines have worked essentially the same way. Patients get an inoculation containing a weakened or killed germ or some of its key proteins. The body’s immune system reacts to it, and the next time the germ shows up, the body can recognize and neutralize it.

Companies grow the germs or germ parts in chicken eggs or vats of live cells. Manufacturing enough vaccine-ready germs or proteins for millions of shots takes a year or more in big manufacturing facilities.

In recent years, though, scientists have started exploring a different approach. Rather than injecting part of the germ itself, experimental vaccines deliver the genetic blueprints for germ parts and let the patient’s own body manufacture them.

The active ingredient in these vaccines is DNA or RNA, the genetic instructions for building proteins.


A lab assistant works on samples after an AP interview with Christian Drosten, director of the institute for virology of Berlin’s Charite hospital on his researches on the coronavirus in Berlin, Germany. VOA

“You don’t even need an infectious virus,” said molecular microbiology professor Andrew Pekosz at Johns Hopkins Bloomberg School of Public Health. All scientists need is the virus’s genetic code. “And that became available very early in this outbreak,” he said.

Vaccine design in three hours

Chinese scientists first announced cases of unusual pneumonia Dec. 31, 2019. By Jan. 11, they had isolated the new coronavirus and published its complete genome.

With the virus’s blueprints in hand, Inovio Pharmaceuticals designed a vaccine in three hours. Manufacturing started the next day.

“It’s pretty remarkable, right?” said Kate Broderick, Inovio’s chief of research and development.

Inovio’s vaccine is based on DNA. Two other companies, Moderna and CureVac, are using what’s called messenger RNA. If DNA is the master blueprint for a protein, mRNA is the working copy taken to the construction site. It’s what the body’s machinery uses to turn blueprints into finished products.


Aedes aegypti mosquitoes are seen in a mosquito cage at a laboratory in Cucuta, Colombia. VOA

Both methods are easily adapted when a new disease appears. Inovio has a vaccine in clinical trials against Middle East respiratory syndrome, caused by another coronavirus. The company also is working on vaccines for Zika, Ebola, Lassa, HIV and others.

DNA and RNA medicines also have the potential to treat cancer. Inovio, Moderna and CureVac are among the companies with genetic therapies in the works for cervical, lung, skin, prostate and other cancers.

The technology has been around for about 20 years, Broderick said, but has made big advances in recent years. There are no human DNA or RNA medicines on the market yet, but there are several for animals, including treatments for West Nile virus in horses, a viral disease in salmon, melanoma in dogs and a gene therapy that produces growth hormone in pigs.

Clinical trials and tribulations

While a DNA or RNA vaccine is quick to make, “what takes time — and it should take time — is the process of testing it,” Broderick said.

After manufacturing, animal safety tests will take a few months. Then the first phase of clinical trials can begin. Phase 1 tests for safety in healthy volunteers will take three months, according to NIAID’s Fauci.

After that, “some vaccines can get emergency approval for use in these epidemics,” Pekosz at Johns Hopkins said, “particularly if they’re the only means by which people can be afforded some level of protection.”


B.K. Morris, a nurse with MedStar Visiting Nurses Association, gives a flu shot to Secretary of Health and Human Services Alex Azar during a news conference in Washington. VOA

Once a vaccine is proved to be safe, researchers then must prove it works. That takes several months more.

By then, the outbreak could be over. That’s what happened with SARS. By the time researchers got an experimental vaccine through phase 1 safety trials, old-fashioned quarantine had stopped the virus from spreading.

“This is always the problem that we have with these outbreaks,” Pekosz said. Once the outbreak is over, “interest in generating the vaccine wanes, and the perceived need for the vaccine then wanes,” he added, “and these vaccines end up in this never-never land of being partially studied, but never pushed all the way through to completion.”

And then another outbreak hits.

Also Read- These Vitamins Can Help You Combat Stress

“We could have done a much better job of preparing for this epidemic if we just followed through on some of the SARS vaccine work all the way to its completion,” he said.

That’s a job government agencies should be doing, he said, “so that we do have data on how good a vaccine is before we actually need it.” (VOA)


Popular

Photo by Ehimetalor Akhere Unuabona on Unsplash

Numerous young people carry on involving themselves with social media without even bothering to consider its effect on them.

Social media is an umbrella term that encompasses all apps, websites, and blogs that allow people from all over the world to interact through the internet. Anyone who wishes to use any social media platform must first sign up and then sign in to view content and communicate with other members of that social media platform. Facebook, Twitter, Instagram, WhatsApp, LinkedIn, and Snapchat are commonly used social media platforms. Social media, like all technological advancements, has both advantages and disadvantages.

Social media has become an essential aspect of life for many youths in today's society. Numerous young people carry on involving themselves with social media without even bothering to consider its effect on them. The consequences may be both good and bad at times. When it comes to the negative impact of social media on teenagers, the majority of the time, they are unfavourable if the activity is not linked with a commercial or professional objective.

Keep Reading Show less
Photo by Elena Mozhvilo on Unsplash

The following five budget-friendly ways shared by Niraj Johri, founder & CEO at Casa Decor, help you decorate your home in a manner that makes it unforgettable.

During festivals like Diwali, one shouldn't only pay pay attention to dressing up, shopping and meeting family members; an integral part of festivities includes cleaning and decorating our homes, neighbourhood and spreading joy. But while anybody can clean their homes, designing new spaces can be a tad bit cumbersome. With a restricted budget and high-priced decor products in the market, everyone is always looking out for new ideas that are both cost-effective and can transform your home to welcome Maa Laxmi and the New Year. Don't worry though, the following five budget-friendly ways shared by Niraj Johri, founder & CEO at Casa Decor, help you decorate your home in a manner that makes it unforgettable.

Adding metal accents
Adding brass, silver, or copper accessories in the tiny little spaces inside your home can elevate its overall design aesthetics. Metals are the epitome of elegance and luxury -- they can be moulded to lend an eccentric and dynamic fusion of colours. Due to their unpredictable nature, artisans can find numerous ways in which they can help accentuate every corner in your home.

Folded into intricate forms with beautiful solid colours, metals are an undeniably fascinating material to use in home decor. In fact, they are known for their polished and refined looks that bring together edgy, contemporary, and Victorian styles to the forefront. Such designs can usually be found in handcrafted decor pieces such as metal trays that are perfect centrepieces on wooden tables.

brown leather pouch beside white and black floral textile Adding brass, silver, or copper accessories in the tiny little spaces inside your home can elevate its overall design aesthetics. | Photo by Priscilla Du Preez on Unsplash

Keep Reading Show less
Wikimedia Commons

Elon Musk has renewed his promise to "extend life to Mars".

Following a huge growth in his personal fortune, Tesla and SpaceX CEO Elon Musk has renewed his promise to "extend life to Mars". According to The Star, Musk's wealth has swelled to an astonishing $230 billion. Or a whopping 861 billion Dodgecoin, a cryptocurrency backed by the entrepreneur after he was reported to have invested millions.

Musk is now richer than Bill Gates and Warren Buffett combined, both individuals who had previously held the rich list title. "Elon Musk (with a net worth equal to 861 billion #Dogecoin) is now richer than Bill Gates and Warren Buffett COMBINED!" popular crypto YouTuber Matt Wallace's tweeted.

To which Musk said: "Hopefully enough to extend life to Mars". "Have no doubt you will make it happen," Wallace responded. CEO investments, the creators of Dogecoin, also responded backing Musk's plans every step of the way. The SpaceX Mars programme was initiated by Musk to colonize Mars after he first conceptualized the project back in 2001. SpaceX's aspirational goal has been to land the first humans on Mars by 2024, but in October 2020 Musk named 2024 as the goal for an uncrewed mission. (IANS/ MBI)

Keywords: investments, combined, SpaceX, billion, Elon musk, tesla